Press Releases

Cipher Pharmaceuticals Schedules Q3 2024 Earnings Release and Conference Call

MISSISSAUGA, ON, Nov. 4, 2024 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced that it will release its financial results for the third quarter of 2024 after the market close on Thursday, November 7, 2024. The Company will also hold a conference call on Friday, November 8, 2024 at 8:30am ET to discuss the results and corporate developments.

CONFERENCE CALL DETAILS

DATE:	Friday, November 8, 2024
TIME:	8:30 a.m. ET
DIAL-IN NUMBER:	416-945-7677 or 888-699-1199
REPLAY:	289-819-1450 or 888-660-6345 Code: 02131#
	Expires: November 15, 2024
WEBCAST:	https://app.webinar.net/BxoA3Pp3dnP

About Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals (TSX: CPH, OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com.

SOURCE Cipher Pharmaceuticals Inc.

For further information: For further information: Graham Farrell, Investor Relations - Cipher Pharmaceuticals, ir@cipherpharma.com, 416-842-9003